216 related articles for article (PubMed ID: 35884916)
1. Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives.
Sato Y; Okamoto K; Kawaguchi T; Nakamura F; Miyamoto H; Takayama T
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884916
[TBL] [Abstract][Full Text] [Related]
2. The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer.
Sun J; Wang X; Zhang Z; Zeng Z; Ouyang S; Kang W
Front Oncol; 2021; 11():641304. PubMed ID: 33937042
[TBL] [Abstract][Full Text] [Related]
3. Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Zhou J; Shen J; Seifer BJ; Jiang S; Wang J; Xiong H; Xie L; Wang L; Sui X
Oncotarget; 2017 May; 8(18):30477-30494. PubMed ID: 27802185
[TBL] [Abstract][Full Text] [Related]
4. Biomarker evaluation in radically resectable locally advanced gastric cancer treated with neoadjuvant chemotherapy: an evidence reappraisal.
Gervaso L; Pellicori S; Cella CA; Bagnardi V; Lordick F; Fazio N
Ther Adv Med Oncol; 2021; 13():17588359211029559. PubMed ID: 34484429
[TBL] [Abstract][Full Text] [Related]
5. The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer.
Koerner AS; Moy RH; Ryeom SW; Yoon SS
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627142
[TBL] [Abstract][Full Text] [Related]
6. [Current status and prospect of perioperative therapy for locally advanced gastric cancer].
Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):101-106. PubMed ID: 33508913
[TBL] [Abstract][Full Text] [Related]
7. Prediction model of objective response after neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
Xu W; Fan Z; Wang L; He C; Ni Z; Hua Z; Zhu Z; Yang Z; Zheng Y; Feng R; Yan C; Li C; Yao X; Chen M; Yan M; Zhu Z; Liu W
Am J Transl Res; 2021; 13(3):1568-1579. PubMed ID: 33841680
[TBL] [Abstract][Full Text] [Related]
8. Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
Fujitani K; Nakamura K; Mizusawa J; Kuwata T; Shimoda T; Katayama H; Kushima R; Taniguchi H; Yoshikawa T; Boku N; Terashima M; Fukuda H; Sano T; Sasako M;
Gastric Cancer; 2021 Jan; 24(1):197-204. PubMed ID: 32572792
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcome of Doublet and Triplet Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
Kim JS; Kang SH; Moon HS; Sung JK; Jeong HY; Sul JY
Korean J Gastroenterol; 2016 Nov; 68(5):245-252. PubMed ID: 27871160
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery.
Tokunaga M; Kurokawa Y; Fukagawa T; Muro K; Shitara K; Kodera Y; Terashima M
Ann Gastroenterol Surg; 2023 Nov; 7(6):856-862. PubMed ID: 37927916
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy-induced severe neutropenia is associated with histopathological response and survival in locally advanced gastric cancer.
Wu C; Wang T; Zhou H; Zhang X; Guo C; Chen Y; Zhao D
Transl Cancer Res; 2020 Jan; 9(1):280-293. PubMed ID: 35117182
[TBL] [Abstract][Full Text] [Related]
13. XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
Wada T; Fukuda T; Shimomura M; Inoue Y; Kawanishi M; Tasaka R; Yasui T; Ikeda K; Sumi T
Oncol Lett; 2018 Mar; 15(3):3766-3771. PubMed ID: 29556276
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis.
Zhang X; Huang H; Wei Z; Zhu Z; Yang D; Fu H; Xu J; Hu Z; Zhang Y; You Q; Huang X; Yan R; Wang W; Cai Q
Cancer Manag Res; 2020; 12():6641-6653. PubMed ID: 32801898
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Chemotherapy
Xu W; Wang L; Yan C; He C; Lu S; Ni Z; Hua Z; Zhu Z; Sah BK; Yang Z; Zheng Y; Feng R; Li C; Yao X; Chen M; Liu W; Yan M; Zhu Z
Front Oncol; 2021; 11():718556. PubMed ID: 34497768
[TBL] [Abstract][Full Text] [Related]
16. Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial.
Oshima T; Yoshikawa T; Miyagi Y; Morita S; Yamamoto M; Tanabe K; Nishikawa K; Ito Y; Matsui T; Kimura Y; Yokose T; Hiroshima Y; Aoyama T; Hayashi T; Ogata T; Cho H; Rino Y; Masuda M; Tsuburaya A; Sakamoto J
Oncotarget; 2020 Jul; 11(30):2906-2918. PubMed ID: 32774771
[TBL] [Abstract][Full Text] [Related]
17. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant treatment for locally advanced gastric cancer].
Zhao LL; Zhao DB; Chen YT
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):907-911. PubMed ID: 33256300
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer.
Tong X; Zhi P; Lin S
J Gastric Cancer; 2023 Jan; 23(1):182-193. PubMed ID: 36750998
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy.
Yeh YS; Chen YT; Tsai HL; Huang CW; Ma CJ; Su WC; Huang CM; Huang MY; Hu HM; Lu CY; Wang JY
Pathol Oncol Res; 2020 Apr; 26(2):1105-1116. PubMed ID: 31077069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
